Device for noninvasive brain biopsies via blood draw moves closer to market approval

November 16, 2023

A device aimed at enabling neurosurgeons and other physicians to perform noninvasive blood-based biopsies in adults with brain tumors has received Food and Drug Administration (FDA) “Breakthrough Device” designation. The device includes technology from Washington University in St. Louis and developed by Cordance Medical Inc., a medical device company in Mountain View, Calif.

Biotech industry leader to helm WashU drug development accelerator

October 18, 2023

Shripad Bhagwat, PhD, a drug development expert with decades of experience in the pharmaceutical and biotech industries, has been named the inaugural senior director of the Needleman Program for Innovation and Commercialization (NPIC) at Washington University in St. Louis. 

WashU leads new multi-omics production center for NIH research consortium

September 28, 2023

The National Institutes of Health (NIH) is channeling $50.3 million over the next five years into a new consortium dedicated to advancing the generation and analysis of multi-omics data for human health research. As part of this team, Washington University in St. Louis is establishing and will lead a central production center that functions as a hub for multi-omics analyses for materials from consortium members at each of six disease study sites identified by the NIH.

Scientists develop breath test that rapidly detects COVID-19 virus

July 31, 2023

Scientists at Washington University in St. Louis have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides results in less than a minute.

Curiel, Diamond receive innovation award

June 23, 2023

David T. Curiel, MD, PhD, and Michael S. Diamond, MD, PhD, both of Washington University School of Medicine in St. Louis, have received the Washington University Chancellor’s Award for Innovation and Entrepreneurship for their development of a nasal vaccine against SARS-CoV-2, the virus that causes COVID-19.

EMBA alum’s startup wins $250K in Texas competition

June 5, 2023

A WashU-based life sciences startup that patented a groundbreaking bloodstream marker that flags potential cardiovascular disease recently won a $250,000 investment prize in a major national pitch competition.

Wearable, light-based brain-imaging tech to be commercialized with aid of NIH grant

May 25, 2023

Wearable brain-imaging tech aims to reveal how the brain works in natural, realistic situations. Washington University faculty members Joseph P. Culver, Jason Trobaugh and Ed Richter, along with Adam Eggebrecht, have received a grant from the NIH to develop and commercialize a brain-imaging cap that uses LED light to gauge brain activity.

Findings may lead to improved insulin-secreting cells derived from stem cells

May 17, 2023

Diabetes researchers at Washington University School of Medicine in St. Louis have uncovered at least one reason insulin-secreting cells made from stem cells in the lab don’t work as well as natural cells. The discovery could help speed progress toward making insulin-secreting cells — called islet beta cells — more effective in the treatment of insulin-dependent Type 1 diabetes.

Viewing 1 - 10 of 30